Chapter 53: Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease
- 1 January 1993
- book chapter
- research article
- Published by Elsevier BV in Progress in brain research
- Vol. 98, 431-438
- https://doi.org/10.1016/s0079-6123(08)62429-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effects of the Novel Acetylcholinesterase Inhibitor SDZ ENA 713 on Sleep in ManNeuropsychopharmacology, 1993
- The Cholinergic Model of Dementia, Alzheimer Type: Progression from the Unitary Transmitter ConceptDementia and Geriatric Cognitive Disorders, 1992
- Pharmacologic and Clinicopharmacologic Properties of SDZ ENA 713, a Centrally Selective Acetylcholinesterase InhibitorAnnals of the New York Academy of Sciences, 1991
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonistEuropean Journal of Pharmacology, 1986
- Acetylcholinesterase may have novel functions in the brainTrends in Neurosciences, 1984
- Effect of muscarinic ligands on the electrical activity recorded from the hippocampus: a quantitative approachBritish Journal of Pharmacology, 1984
- The Molecular Forms of Cholinesterase and Acetylcholinesterase in VertebratesAnnual Review of Neuroscience, 1982
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961
- The determination of enzyme inhibitor constantsBiochemical Journal, 1953